APA (7th ed.) Citation

Sardar Kader, Kassim J.Al-Shamma, Ibrahim A. Majeed, & Abdulla T. Al-Ani. (2017). Comparative Study between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. College of Pharmacy University of Baghdad.

Chicago Style (17th ed.) Citation

Sardar Kader, Kassim J.Al-Shamma, Ibrahim A. Majeed, and Abdulla T. Al-Ani. Comparative Study Between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. College of Pharmacy University of Baghdad, 2017.

MLA (9th ed.) Citation

Sardar Kader, et al. Comparative Study Between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients. College of Pharmacy University of Baghdad, 2017.